BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 165831)

  • 21. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
    Kurokawa Y; Fukuda I; Mozai T
    Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
    [No Abstract]   [Full Text] [Related]  

  • 22. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional pool of cyclic adenosine 3',5'-monophosphate in rabbit platelets.
    Hashimoto S
    Thromb Haemost; 1983 Feb; 49(1):8-12. PubMed ID: 6302940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for regulatory control of canine platelet phosphodiesterase.
    Boudreaux MK; Dodds WJ; Slauson DO; Catalfamo JL
    Biochem Biophys Res Commun; 1986 Oct; 140(2):589-94. PubMed ID: 3022725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
    Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
    Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.
    Stefanovich V
    Arzneimittelforschung; 1975 May; 25(5):740-1. PubMed ID: 170944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.
    Scher NS; Quagliata F; Malathi VG; Faig D; Melton RA; Silber R
    Cancer Res; 1976 Nov; 36(11 Pt 1):3958-62. PubMed ID: 184920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic nucleotide phosphodiesterases in uterine development.
    Stancel GM; Thompson WJ; Strada SJ
    Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
    Taylor PM; Heptinstall S
    Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
    [No Abstract]   [Full Text] [Related]  

  • 31. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of nucleoside cyclic 3':5'-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3526-30. PubMed ID: 4357877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.
    Pyne NJ; Cooper ME; Houslay MD
    Biochem J; 1986 Mar; 234(2):325-34. PubMed ID: 3013156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic nucleotide phosphodiesterase activities of the fetal and mature human cerebral cortex.
    Kang ES
    Pediatr Res; 1977 May; 11(5):655-63. PubMed ID: 193085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on adenosine 3',5'-monophosphate phosphodiesterase of human erythrocyte membranes.
    Suzuki K; Terao T; Osawa T
    Biochim Biophys Acta; 1980 Oct; 602(1):78-86. PubMed ID: 6251888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat-stable low molecular weight form of phosphodiesterases from bovine pineal gland.
    Sankaran K; Hanbauer I; Lovenberg W
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3188-91. PubMed ID: 210451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
    Biochem J; 1975 Jan; 146(1):109-20. PubMed ID: 167710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in the hydrolytic activity, inhibitor sensitivity and molecular size of the rat erythrocyte cyclic AMP phosphodiesterase by calcium and hypertonic sodium chloride.
    Sheppard H; Tsien WH
    J Cyclic Nucleotide Res; 1975; 1(4):237-42. PubMed ID: 177464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple cyclic nucleotide phosphodiesterases in rat kidney.
    Gulyassy PF; Farrand JR; Gugler HD
    Kidney Int; 1975 Nov; 8(5):284-91. PubMed ID: 537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.